Gene therapy for macular degeneration: is it safe years later?
Disease control
Ongoing
This study follows 18 people who already received RetinoStat, a gene therapy for wet age-related macular degeneration, to see if it remains safe over time. Researchers track side effects and vision changes. The goal is to understand long-term risks, not to test if the treatment w…
Phase: PHASE1 • Sponsor: Oxford BioMedica • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC